Favorable Early Outcomes for Patients with Extended Indications for Thoracic Endografting


  • Kirk A. Caddell
  • Howard K. Song
  • Gregory J. Landry
  • Kenneth J. Kolbeck
  • Matthew S. Slater
  • Timothy K. Liem
  • Steven Guyton
  • Gregory Moneta
  • John A. Kaufman




Background: Endografts originally designed and approved for the treatment of thoracic aortic aneurysms have rapidly been adopted for nonapproved use in the treatment of disorders of the thoracic aorta, including aortic transection, dissection, pseudoaneurysms, and thoracoabdominal aneurysms. The purpose of this study was to evaluate the early outcomes of patients treated with thoracic endografts for nonapproved indications at our institution.

Methods: The medical records of patients undergoing thoracic endografting at our institution from August 2005 until March 2008 were reviewed. Patients undergoing endografting for uncomplicated thoracic aortic aneurysms were excluded. The outcomes of patients with extended indications for thoracic endografting were studied.

Results: During the study period, endografting was performed in 31 patients for nonapproved aortic conditions. Patients underwent endografting for a spectrum of indications, including aortic transection (n = 12), complications of type B aortic dissection including rupture (n = 9), thoracoabdominal aneurysm with visceral debranching (n = 6), aortic arch debranching (n = 2), and pseudoaneurysm associated with prior coarctation repair (n = 2). Early outcomes were favorable. All patients had successful endograft repair of their anatomic lesion. There were no endoleaks. There was no hospital mortality. Average hospitalization was 15 days for patients with aortic transection and 9 days for all other patients.

Conclusions: Thoracic endografts are versatile devices that with appropriate expertise can be used effectively to treat a spectrum of disorders of the thoracic aorta, including acute emergencies. Early outcomes of patients with extended indications for thoracic endografting compare favorably to published series of patients treated with open procedures. Further study is required to assess the long-term efficacy of these devices.


Bavaria JE, Appoo JJ, Makaroun MS, et al. 2007. Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: a multicenter comparative trial [see comment]. J Thorac Cardiovasc Surg 133:369-77.nCoady MA, Rizzo JA, Goldstein LJ, Elefteriades JA. 1999. Natural history, pathogenesis, and etiology of thoracic aortic aneurysms and dissections. Cardiol Clin 17:615-35.nElefteriades JA, Lovoulos CJ, Coady MA, Tellides G, Kopf GS, Rizzo JA. 1999. Management of descending aortic dissection. Ann Thorac Surg 67:2002-5; discussion 2014-9.nFabian TC, Richardson JD, Croce MA, et al. 1997. Prospective study of blunt aortic injury: Multicenter Trial of the American Association for the Surgery of Trauma. J Trauma 42:374-80; discussion 380-3.nFairman RM, Criado F, Farber M, et al. 2008. Pivotal results of the Medtronic Vascular Talent Thoracic Stent Graft System: the VALOR trial. J Vasc Surg 48:546-54.nFann JI, Sarris GE, Mitchell RS, et al. 1990. Treatment of patients with aortic dissection presenting with peripheral vascular complications. Ann Surg 212:705-13.nFann JI, Smith JA, Miller DC, et al. 1995. Surgical management of aortic dissection during a 30-year period. Circulation 92:II113-21.nGammie JS, Shah AS, Hattler BG, et al. 1998. Traumatic aortic rupture: diagnosis and management [see comment]. Ann Thorac Surg 66:1295-300.nGlower DD, Fann JI, Speier RH, et al. 1990. Comparison of medical and surgical therapy for uncomplicated descending aortic dissection. Circulation 82:IV39-46.nHassoun HT, Matsumura JS. 2006. The COOK TX2 thoracic stent graft: preliminary experience and trial design. Semin Vasc Surg 19:32-9.nHoornweg LL, Dinkelman MK, Goslings JC, et al. 2006. Endovascular management of traumatic ruptures of the thoracic aorta: a retrospective multicenter analysis of 28 cases in the Netherlands. J Vasc Surg 43:1096-102; discussion 1102.nJohansson G, Markström U, Swedenborg J. 1995. Ruptured thoracic aortic aneurysms: a study of incidence and mortality rates. J Vasc Surg 21:985-8.nKaufman JA, Song HK, Ham BB, Slater MS. 2007. Traumatic thoracic aortic transection in small-diameter aortas: percutaneous endograft repair. J Vasc Interv Radiol 18:1429-33.nLansman SL, Hagl C, Fink D, et al. 2002. Acute type B aortic dissection: surgical therapy. Ann Thorac Surg 74:S1833-5; discussion S1857-63.nMakaroun MS, Dillavou ED, Kee ST, et al. 2005. Endovascular treatment of thoracic aortic aneurysms: results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis. J Vasc Surg 41:1-9.nMoainie SL, Neschis DG, Gammie JS, et al. 2008. Endovascular stenting for traumatic aortic injury: an emerging new standard of care. Ann Thorac Surg 85:1625-9; discussion 1629-30.nOrend KH, Kotsis T, Scharrer-Pamler R, et al. 2002. Endovascular repair of aortic rupture due to trauma and aneurysm. Eur J Vasc Endovasc Surg 23:61-7.nOrford VP, Atkinson NR, Thomson K, et al. 2003. Blunt traumatic aortic transection: the endovascular experience. Ann Thorac Surg 75:106-11; discussion 111-2.nSafi HJ, Miller CC 3rd, Reardon MJ, et al. 1998. Operation for acute and chronic aortic dissection: recent outcome with regard to neurologic deficit and early death. Ann Thorac Surg 66:402-11.nSchor JS, Yerlioglu ME, Galla JD, Lansman SL, Ergin MA, Griepp RB. 1996. Selective management of acute type B aortic dissection: long-term follow-up. Ann Thorac Surg 61:1339-41.nSzeto WY, McGarvey M, Pochettino A, et al. 2008. Results of a new surgical paradigm: endovascular repair for acute complicated type B aortic dissection. Ann Thorac Surg 86:87-93; discussion 93-4.nUmana JP, Miller DC, Mitchell RS. 2002. What is the best treatment for patients with acute type B aortic dissections—medical, surgical, or endovascular stent-grafting? Ann Thorac Surg 74:S1840-3; discussion S1857-63.nvon Oppell UO, Dunne TT, De Groot MK, Zilla P. 1994. Traumatic aor-ticrupture: twenty-year metaanalysis of mortality and risk of paraplegia. Ann Thorac Surg 58:585-93.nWheatley GH 3rd, Gurbuz AT, Rodriguez-Lopez JA, et al. 2006. Midterm outcome in 158 consecutive Gore TAG thoracic endoprostheses: single center experience. Ann Thorac Surg 81:1570-7; discussion 1577.n



How to Cite

Caddell, K. A., Song, H. K., Landry, G. J., Kolbeck, K. J., Slater, M. S., Liem, T. K., Guyton, S., Moneta, G., & Kaufman, J. A. (2009). Favorable Early Outcomes for Patients with Extended Indications for Thoracic Endografting. The Heart Surgery Forum, 12(4), E187-E193. https://doi.org/10.1532/HSF98.20091031